Sobi

About Sobi

Sobi is a specialty pharmaceutical company focused on improving the lives of people living with rare and orphan diseases, particularly those affecting metabolism and lipid disorders. The company specializes in the development and commercialization of treatments for conditions such as FSC (Familial Chylomicronemia Syndrome) and sTGH (Severe Triglyceridemia), with a mission centered on patient-centric care and appropriate disease identification. Sobi operates internationally with a strong emphasis on cross-regional collaboration, leveraging digital engagement, medical affairs expertise, and market access strategies to ensure timely patient diagnosis and treatment adoption. The company integrates scientific insights with commercial execution to create scalable frameworks and omnichannel engagement approaches for healthcare providers, payers, and patient organizations.